AdaptHealth Corp. (AHCO) vs Attovia Therapeutics, Inc. (ATTO)
A side-by-side comparison of AdaptHealth Corp. and Attovia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AHCO
AdaptHealth Corp.
$5.78HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
ATTO
Attovia Therapeutics, Inc.
$17.74HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
Total return — AHCO vs ATTO
growth of $100 · dividends reinvested · last 1yAHCO -11.7% (-11.7%/yr)ATTO -17.8% (-17.8%/yr)AHCO compounded faster over this window
AHCO ATTO
AHCO vs ATTO: by the numbers
- •AHCO is the larger company ($786M vs $763M market cap).
- •Both run net losses; AHCO's is the smaller (-7.58% vs -4490.89% net margin).
Metrics side by side
Valuation
| Metric | AHCO | ATTO |
|---|---|---|
| P/S ratio | 0.26 | N/A |
| P/B ratio | 0.57 | N/A |
| EV / EBITDA | 6.63 | N/A |
| FCF yield | 12.42% | N/A |
Profitability
| Metric | AHCO | ATTO |
|---|---|---|
| Gross margin | 10.37% | 40.44% |
| Operating margin | -0.31% | -4974.74% |
| Net margin | -7.58% | -4490.89% |
| ROE | -16.56% | -40.21% |
| ROIC | -0.26% | -42.83% |
Growth (annualized)
| Metric | AHCO | ATTO |
|---|---|---|
| Revenue CAGR (5Y) | 11.68% | N/A |
| FCF CAGR (5Y) | 7.07% | N/A |
| Total return CAGR (5Y) | -24.65% | N/A |
Go deeper
Dig into the metrics
AdaptHealth ROEAttovia Therapeutics ROEAdaptHealth operating marginAttovia Therapeutics operating marginAdaptHealth revenue growthAttovia Therapeutics revenue growthAdaptHealth free cash flowAttovia Therapeutics free cash flow
AdaptHealth & Attovia Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.